ArticleACS omega2021

Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway.

Jinbiao Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.